Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results From the Phase 2b Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome

被引：0
|
作者：
Gilbert, D. L.
Karkanias, G. B.
Atkinson, S. D.
Munschauer, F.
Wanaski, S.
Cunniff, T.
机构：
来源：
ANNALS OF NEUROLOGY | 2025年 / 96卷
关键词：
Experimental Therapeutics; Movement Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
97
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [31] Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
    Wu, Di
    Li, Jing
    Xu, Dong
    Merrill, Joan T.
    van Vollenhoven, Ronald F.
    Liu, Yi
    Hu, Jiankang
    Li, Yang
    Li, Fen
    Huang, Chenghui
    Wang, Guochun
    Li, Xiaomei
    Zhao, Jianhong
    Zhao, Dongbao
    Huang, Cibo
    Liu, Huaxiang
    Wei, Wei
    Shi, Guixiu
    Lu, Fuai
    Zuo, Xiaoxia
    Bi, Liqi
    Li, Zhijun
    Wang, Xiaoxia
    Zhang, Miaojia
    Tie, Ning
    Li, Juan
    Mo, Hanyou
    Fang, Jianmin
    Bao, Chunde
    Zhang, Fengchun
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 475 - 487
  • [32] OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
    Aurora, S. K.
    Dodick, D. W.
    Turkel, C. C.
    DeGryse, R. E.
    Silberstein, S. D.
    Lipton, R. B.
    Diener, H. C.
    Brin, M. F.
    CEPHALALGIA, 2010, 30 (07) : 793 - 803
  • [33] PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial
    de Ridder, Inger R.
    den Hertog, Heleen M.
    van Gemert, H. Maarten A.
    Schreuder, A. H. C. M. L.
    Ruitenberg, Annemieke
    Maasland, E.
    Saxena, Ritu
    van Tuijl, Jordie H.
    Jansen, Ben P. W.
    Van den Berg-Vos, Renske M.
    Vermeij, Frederique
    Koudstaal, Peter J.
    Kappelle, L. Jaap
    Algra, Ale
    van der Worp, H. Bart
    Dippel, Diederik W. J.
    STROKE, 2017, 48 (04) : 977 - 982
  • [34] Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
    DuBois, Janet
    Bruce, Suzanne
    Stewart, Daniel
    Kempers, Steven
    Harutunian, Christy
    Boodhoo, Terry
    Weitzenfeld, Amy
    Chang-Lin, Joan-En
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2021, 14 : 1507 - 1517
  • [35] A phase 2b double-blind placebo-controlled randomized clinical trial of SB-061, an aggrecan mimetic, in patients with symptomatic knee osteoarthritis
    Bihlet, Asger R.
    Byrjalsen, Inger
    Mundbjerg, Kamilla
    Rovsing, Helene
    Axelsen, Tobias Melton
    Andersen, Jeppe Ragnar
    Metnik, Anna
    Bachtell, Nathan
    Brett, Alan
    Alexandersen, Peter
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 (11) : 1471 - 1480
  • [36] EFFECT OF TADALAFIL IN IMPROVING BPH/LUTS: PRELIMINARY RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL TRIAL
    Rastrelli, Giulia
    Cipriani, Sarah
    Lotti, Francesco
    Cellai, Ilaria
    Comeglio, Paolo
    Filippi, Sandra
    Marzano, Mauro
    Rosi, Martina
    Boni, Luca
    Venturini, Stefano
    Santi, Raffaella
    Nesi, Gabriella
    Serni, Sergio
    Gacci, Mauro
    Maggi, Mario
    Vignozzi, Linda
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (11): : S97 - S97
  • [37] Responder Rates to Atogepant in Patients With Episodic Migraine: A Post Hoc Analysis of Results From a Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Dodick, David W.
    Ailani, Jessica
    Goadsby, Peter J.
    Trugman, Joel M.
    Finnegan, Michelle
    Lakkis, Hassan
    Li, Ye
    Szegedi, Armin
    CEPHALALGIA, 2019, 39 : 183 - 184
  • [38] Responder Rates to Atogepant in Patients with Episodic Migraine: A Post Hoc Analysis of Results from a Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Dodick, D. W.
    Ailani, J.
    Goadsby, P. J.
    Trugman, J. M.
    Finnegan, M.
    Lakkis, H.
    Li, Y.
    Szegedi, A.
    HEADACHE, 2019, 59 : 79 - 80
  • [39] A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
    McGarvey, Lorcan
    Smith, Jaclyn A.
    Morice, Alyn
    Birring, Surinder S.
    Chung, Kian Fan
    Dicpinigaitis, Peter, V
    Niimi, Akio
    Benninger, Michael S.
    Sher, Mandel
    Matsunaga, Yuko
    Miyazaki, Sayaka
    Machida, Mitsuaki
    Ishihara, Hiroyuki
    Mahmood, Adnan
    Gomez, Juan-Carlos
    LUNG, 2023, 201 (01) : 25 - 35
  • [40] Evaluation of the effect of melatonin in patients with Burning mouth syndrome: a double-blind, placebo-controlled randomized clinical trial
    Nosratzehi, Tahereh
    Payandeh, Abolfazl
    Arbab, Kosar
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 59
12345